Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation

Virology

Volumn 425, Issue 2, 2012, Pages 71-81

  Pulit Penaloza, Joanna A ^a   Scherbik, Svetlana V ^a   Brinton, Margo A ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Interferon stimulated gene; Oas1a; Oas1b; Promoter analysis

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN;

2' 5' OLIGOADENYLATE SYNTHETASE 1A GENE; 2' 5' OLIGOADENYLATE SYNTHETASE 1B GENE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOKINE RESPONSIVE ELEMENT; DNA BASE COMPOSITION; FLAVIVIRUS; GENE ACTIVATION; GENE ACTIVITY; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE MAPPING; IMMUNE RESPONSE GENE; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; UPREGULATION;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; BASE SEQUENCE; BINDING SITES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERFERON-BETA; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

FLAVIVIRUS; MURINAE;

EID: 84857030562     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.11.025     Document Type: Article

References (75)

1. Andersen J., VanScoy S., Cheng T.F., Gomez D., Reich N.C. IRF-3-dependent and augmented target genes during viral infection. Genes Immun. 2008, 9:168-175.
2. Barnes B.J., Richards J., Mancl M., Hanash S., Beretta L., Pitha P.M. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 2004, 279:45194-45207.
3. Basagoudanavar S.H., Thapa R.J., Nogusa S., Wang J., Beg A.A., Balachandran S. Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses. J. Virol. 2011, 85:2599-2610.
4. Bluyssen H.A., Levy D.E. Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J. Biol. Chem. 1997, 272:4600-4605.
5. Bluyssen H.A., Muzaffar R., Vlieststra R.J., van der Made A.C., Leung S., Stark G.R., Kerr I.M., Trapman J., Levy D.E. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:5645-5649.
6. Bonnevie-Nielsen V., Field L.L., Lu S., Zheng D.J., Li M., Martensen P.M., Nielsen T.B., Beck-Nielsen H., Lau Y.L., Pociot F. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am. J. Hum. Genet. 2005, 76:623-633.
7. Brandes C., Plautz J.D., Stanewsky R., Jamison C.F., Straume M., Wood K.V., Kay S.A., Hall J.C. Novel features of drosophila period transcription revealed by real-time luciferase reporting. Neuron 1996, 16:687-692.
8. Chang T.H., Liao C.L., Lin Y.L. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 2006, 8:157-171.
9. Chen P.J., Wei C.C., Wang C., Chen F.W., Hsu Y.H., Chang M.S. Promoter analysis of interleukin 19. Biochem. Biophys. Res. Commun. 2006, 344:713-720.
10. Currie R.A. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J. Biol. Chem. 1998, 273:1430-1434.
11. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
12. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
13. Decker T., Kovarik P., Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 1997, 17:121-134.
14. Diamond M.S. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J. Interferon Cytokine Res. 2009, 29:521-530.
15. Dolfini D., Zambelli F., Pavesi G., Mantovani R. A perspective of promoter architecture from the CCAAT box. Cell Cycle 2009, 8:4127-4137.
16. Ehret G.B., Reichenbach P., Schindler U., Horvath C.M., Fritz S., Nabholz M., Bucher P. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 2001, 276:6675-6688.
17. Elbahesh H., Jha B.K., Silverman R.H., Scherbik S.V., Brinton M.A. The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells. Virology 2011, 409:262-270.
18. Elco C.P., Guenther J.M., Williams B.R., Sen G.C. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. J. Virol. 2005, 79:3920-3929.
19. Eskildsen S., Hartmann R., Kjeldgaard N.O., Justesen J. Gene structure of the murine 2'-5'-oligoadenylate synthetase family. Cell. Mol. Life Sci. 2002, 59:1212-1222.
20. Eskildsen S., Justesen J., Schierup M.H., Hartmann R. Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res. 2003, 31:3166-3173.
21. Floyd-Smith G., Wang Q., Sen G.C. Transcriptional induction of the p69 isoform of 2',5'-oligoadenylate synthetase by interferon-beta and interferon-gamma involves three regulatory elements and interferon-stimulated gene factor 3. Exp. Cell Res. 1999, 246:138-147.
22. Garban H.J., Bonavida B. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J. Immunol. 2001, 167:75-81.
23. George C.X., Das S., Samuel C.E. Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon. Virology 2008, 380:338-343.
24. Grandvaux N., Servant M.J., tenOever B., Sen G.C., Balachandran S., Barber G.N., Lin R., Hiscott J. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 2002, 76:5532-5539.
25. Grilli M., Chiu J.J., Lenardo M.J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 1993, 143:1-62.
26. Guo Z., Garg S., Hill K.M., Jayashankar L., Mooney M.R., Hoelscher M., Katz J.M., Boss J.M., Sambhara S. A distal regulatory region is required for constitutive and IFN-beta-induced expression of murine TLR9 gene. J. Immunol. 2005, 175:7407-7418.
27. Hahm B., Trifilo M.J., Zuniga E.I., Oldstone M.B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 2005, 22:247-257.
28. Hartmann R., Olsen H.S., Widder S., Jorgensen R., Justesen J. p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase family. Nucleic Acids Res. 1998, 26:4121-4128.
29. Higai K., Miyazaki N., Azuma Y., Matsumoto K. Transcriptional regulation of the fucosyltransferase VI gene in hepatocellular carcinoma cells. Glycoconj. J. 2008, 25:225-235.
30. Hovnanian A., Rebouillat D., Mattei M.G., Levy E.R., Marie I., Monaco A.P., Hovanessian A.G. The human 2',5'-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. Genomics 1998, 52:267-277.
31. Hovnanian A., Rebouillat D., Levy E.R., Mattei M.G., Hovanessian A.G. The human 2',5'-oligoadenylate synthetase-like gene (OASL) encoding the interferon-induced 56-kDa protein maps to chromosome 12q24.2 in the proximity of the 2',5'-OAS locus. Genomics 1999, 56:362-363.
32. Jackson S.M., Ericsson J., Mantovani R., Edwards P.A. Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein. J. Lipid Res. 1998, 39:767-776.
33. Jin S., Scotto K.W. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 1998, 18:4377-4384.
34. Justesen J., Hartmann R., Kjeldgaard N.O. Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell. Mol. Life Sci.. 2000, 57:1593-1612.
35. Kabe Y., Yamada J., Uga H., Yamaguchi Y., Wada T., Handa H. NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Mol. Cell. Biol. 2005, 25:512-522.
36. Kakuta S., Shibata S., Iwakura Y. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family. J. Interferon Cytokine Res. 2002, 22:981-993.
37. Kaur S., Uddin S., Platanias L.C. The PI3' kinase pathway in interferon signaling. J. Interferon Cytokine Res. 2005, 25:780-787.
38. Kowenz-Leutz E., Leutz A. A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell 1999, 4:735-743.
39. Kraus T.A., Lau J.F., Parisien J.P., Horvath C.M. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response. J. Biol. Chem. 2003, 278:13033-13038.
40. Li Q., Herrler M., Landsberger N., Kaludov N., Ogryzko V.V., Nakatani Y., Wolffe A.P. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo. EMBO J. 1998, 17:6300-6315.
41. Lindas A.C., Tomkinson B. Characterization of the promoter of the gene encoding human tripeptidyl-peptidase II and identification of upstream silencer elements. Gene 2007, 393:62-69.
42. Lou Y.J., Pan X.R., Jia P.M., Li D., Xiao S., Zhang Z.L., Chen S.J., Chen Z., Tong J.H. IRF-9/STAT2 functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res. 2009, 69:3673-3680.
43. Mantovani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999, 239:15-27.
44. Mashimo T., Glaser P., Lucas M., Simon-Chazottes D., Ceccaldi P.E., Montagutelli X., Despres P., Guenet J.L. Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2',5'-oligoadenylate synthetases. Genomics 2003, 82:537-552.
45. Merika M., Thanos D. Enhanceosomes. Curr. Opin. Genet. Dev. 2001, 11:205-208.
46. Nakaya T., Sato M., Hata N., Asagiri M., Suemori H., Noguchi S., Tanaka N., Taniguchi T. Gene induction pathways mediated by distinct IRFs during viral infection. Biochem. Biophys. Res. Commun. 2001, 283:1150-1156.
47. Ousman S.S., Wang J., Campbell I.L. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J. Virol. 2005, 79:7514-7527.
48. Perelygin A.A., Scherbik S.V., Zhulin I.B., Stockman B.M., Li Y., Brinton M.A. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9322-9327.
49. Perelygin A.A., Zharkikh A.A., Scherbik S.V., Brinton M.A. The mammalian 2'-5' oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla. J. Mol. Evol. 2006, 63:562-576.
50. Perry S.T., Buck M.D., Lada S.M., Schindler C., Shresta S. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 2011, 7:e1001297.
51. Peters K.L., Smith H.L., Stark G.R., Sen G.C. IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6322-6327.
52. Qureshi S.A., Salditt-Georgieff M., Darnell J.E. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:3829-3833.
53. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89:1-47.
54. Rebouillat D., Marie I., Hovanessian A.G. Molecular cloning and characterization of two related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2'-5' oligoadenylate synthetase. Eur. J. Biochem. 1998, 257:319-330.
55. Rebouillat D., Hovnanian A., David G., Hovanessian A.G., Williams B.R. Characterization of the gene encoding the 100-kDa form of human 2',5' oligoadenylate synthetase. Genomics 2000, 70:232-240.
56. Reith W., Siegrist C.A., Durand B., Barras E., Mach B. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:554-558.
57. Rutherford M.N., Kumar A., Nissim A., Chebath J., Williams B.R. The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucleic Acids Res. 1991, 19:1917-1924.
58. Salsi V., Caretti G., Wasner M., Reinhard W., Haugwitz U., Engeland K., Mantovani R. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J. Biol. Chem. 2003, 278:6642-6650.
59. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809. (table of contents).
60. Sarkis P.T., Ying S., Xu R., Yu X.F. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J. Immunol. 2006, 177:4530-4540.
61. Scherbik S.V., Paranjape J.M., Stockman B.M., Silverman R.H., Brinton M.A. RNase L plays a role in the antiviral response to West Nile virus. J. Virol. 2006, 80:2987-2999.
62. Scherbik S.V., Stockman B.M., Brinton M.A. Differential expression of interferon (IFN) regulatory factors and IFN-stimulated genes at early times after West Nile virus infection of mouse embryo fibroblasts. J. Virol. 2007, 81:12005-12018.
63. Shibata S., Kakuta S., Hamada K., Sokawa Y., Iwakura Y. Cloning of a novel 2',5'-oligoadenylate synthetase-like molecule, Oasl5 in mice. Gene 2001, 271:261-271.
64. Smale S.T. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta 1997, 1351:73-88.
65. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell 1989, 57:103-113.
66. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
67. Su Z.Z., Sarkar D., Emdad L., Barral P.M., Fisher P.B. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. J. Cell. Physiol. 2007, 213:502-510.
68. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell. Microbiol. 2006, 8:907-922.
69. Taniguchi T., Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat. Rev. Mol. Cell Biol. 2001, 2:378-386.
70. Tenoever B.R., Ng S.L., Chua M.A., McWhirter S.M., Garcia-Sastre A., Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007, 315:1274-1278.
71. Thompson J.F., Hayes L.S., Lloyd D.B. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991, 103:171-177.
72. Wang Q., Floyd-Smith G. The p69/71 2-5A synthetase promoter contains multiple regulatory elements required for interferon-alpha-induced expression. DNA Cell Biol. 1997, 16:1385-1394.
73. Wright K.L., Moore T.L., Vilen B.J., Brown A.M., Ting J.P. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J. Biol. Chem. 1995, 270:20978-20986.
74. Yan W., Ma L., Stein P., Pangas S.A., Burns K.H., Bai Y., Schultz R.M., Matzuk M.M. Mice deficient in oocyte-specific oligoadenylate synthetase-like protein OAS1D display reduced fertility. Mol. Cell. Biol. 2005, 25:4615-4624.
75. Yu F., Wang Q., Floyd-Smith G. Transcriptional induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha is stimulated by 12-O-tetradecanoyl phorbol-13-acetate through IRF/ISRE binding motifs. Gene 1999, 237:177-184.